Fundraising FoxAllosteRx Capital Management (Canada) Inc.
Venture capitalMontreal · Seed–Series A · 1 people tracked
Also known as AllosteRx Capital
Find your way into AllosteRx Capital Management (Canada) Inc.
Sign up to see every warm intro you have to AllosteRx Capital Management (Canada) Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AllosteRx Capital Management (Canada) Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
AllosteRx Capital focuses on catalyzing early-stage biotechnology innovation, with a particular emphasis on backing companies and institutions in under-ventured regions of the United States and Canada. The firm targets early-stage biotech ventures, aiming to support scientific innovation emerging from areas and institutions that have historically received less venture funding.
Source: firm website, verified Oct 10, 2026.
Team · 1 people
from curated
David Lowe is a Kauffman Fellow, a member of Class 7 of the two-year venture capital leadership program run by Kauffman Fellows. The program's member directory lists them at AllosteRx Capital in United States.
Frequently asked questions
- What stage does AllosteRx Capital Management (Canada) Inc. invest at?
- AllosteRx Capital Management (Canada) Inc. invests at the Seed, Series A stages.
- What sectors does AllosteRx Capital Management (Canada) Inc. focus on?
- AllosteRx Capital Management (Canada) Inc. focuses on Biotech, Healthtech, IoT, Sector Agnostic.
- Where is AllosteRx Capital Management (Canada) Inc. located?
- AllosteRx Capital Management (Canada) Inc. is headquartered in Montreal, CA.
Similar investors
Connecticut Innovations is the state of Connecticut's venture capital arm, providing financing and ongoing strategic support to innovative, growing companies based in Connecticut.
Lauder Partners is the venture investment vehicle of Gary Lauder, investing in early- and growth-stage private companies across a broad range of technology, healthcare, energy and consumer sectors.
VIVES is an investment fund initiated by UCLouvain (Université catholique de Louvain) in Belgium, focused on backing spin-offs emerging from university research.
Clarendon Fund Managers Limited is a Belfast-based venture capital fund manager, regulated by the FCA, that manages regional VC funds focused on Northern Irish businesses. Since 2001 it has invested in over 80 companies and currently manages £94m of regional VC funds.
BDC Fund Investments is the fund-of-funds arm of BDC Capital, the venture capital division of Canada's Business Development Bank, acting as a limited partner that backs fund managers investing in technology-focused Canadian companies.